Krakow_EHDN
Krakow_EHDN_Mobile

Neurologic

European Huntington Disease Network (EHDN) 2026

Congress Details

calanderOctober 22-24, 2026

locationKrakow, Poland

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Image
Oral

Agenda

23 October, 2026

Coming soon
Image
icon Presentation Type
Oral Presentation
Image
time icon Time
08:45 - 09:45 CEST
Image
location icon Location
TBA
Image
icon Title
Interim Data From a Phase 1b Study of ALN-HTT02, an Investigational RNA Interference Therapeutic Targeting Exon 1 of Huntingtin for HTT-lowering in Patients with Huntington's Disease